Hemolysis clinical trials
The registry lists 184 studies for Hemolysis across more than 10 countries. 42 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-23.
Status
- Completed
- 87
- Recruiting
- 31
- Status unknown
- 25
- Terminated
- 14
- Withdrawn
- 12
- Not yet recruiting
- 9
Phase
- Phase 2
- 44
- Phase 3
- 21
- Phase 1
- 17
- Early Phase 1
- 4
- Phase 4
- 4
Where
- United States
- 59
- France
- 30
- Italy
- 24
- Canada
- 22
- United Kingdom
- 21
- China
- 20
Who runs them
Alexion Pharmaceuticals, Inc. (21) · Assiut University (9) · Institute of Hematology & Blood Diseases Hospital, China (8) · National Heart, Lung, and Blood Institute (NHLBI) (4) · Hospices Civils de Lyon (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · Rigel Pharmaceuticals (3) · Massachusetts General Hospital (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 184 — search for more.
- Pneumatic Tube System Versus Personnel Transport and the Hemolysis Index of Emergency Department Blood Samples: A Randomized, Split-Sample, Single-Blind TrialRecruitingNCT07755007Not applicable1 country
- Wise Practice of Chinese Hemodialysis (WISHES)RecruitingNCT030019211 country
- A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism DisordersRecruitingNCT060923461 country
- A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 GlomerulopathyRecruitingNCT074161621 country
- Danicopan Early Access ProgramAvailableNCT059829381 country
- Ravulizumab in Pregnancies Complicated by Severe Hypertensive DisordersRecruitingNCT06333652Phase 21 country
- Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Undergoing Cesarean Section With Major Obstetric HemorrhageRecruitingNCT07466719Not applicable1 country
- Feasibility Performance Study of ABL90 FLEX PLUS HEMRecruitingNCT073450911 country
- Modeling Blood Management and Hemolytic Risk in Pediatric Heart SurgeryRecruitingNCT067214551 country
- Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular HemolysisRecruitingNCT06449001Phase 33 countries
- National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic AnemiaRecruitingNCT070190381 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931682 countries
- Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal AnemiaRecruitingNCT069844451 country
- Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney InjuryRecruitingNCT06349577Not applicable1 country
- UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Autoimmune Hemolytic AnemiaNot yet recruitingNCT06920446Early Phase 1
- Second-line Treatment of Primary Autoimmune Hemolytic AnemiaRecruitingNCT05057468Phase 31 country
- Ventilatory Functions and Physical Intolerance in ESRD Adolescents: Response to Program of Walking With DogsRecruitingNCT06861816Not applicable1 country
- Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in HemodialysisRecruitingNCT06806891Not applicable1 country
- A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic AnemiaNot yet recruitingNCT06770504Phase 1
- Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of NewbornRecruitingNCT04218318Not applicable1 country
- Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic AnemiaNot yet recruitingNCT06743854
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.RecruitingNCT06733610Phase 11 country
- Study of Acquired Hemolytic Anemia in Adult Hospitalized PatientsNot yet recruitingNCT067087281 country
- SISIPUSH: Evaluation of Hemolysis and Iatrogenic Anemia Using the Push-pull Method to Obtain Blood from Pediatric Patients with Central Venous CathetersRecruitingNCT06657534Not applicable1 country
- Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune NeutropeniaRecruitingNCT059317181 country
- Development of an Innovative Hemodialysis Method to Improve Dialytic Clearance of Protein-bound Uremic ToxinsNot yet recruitingNCT06595680Phase 21 country
- Renal Function and Hemolysis After Pulsed-field Ablation for Atrial FibrillationRecruitingNCT061989331 country
- Effect of Food of NTQ5082 in Healthy SubjectsNot yet recruitingNCT06558656Phase 11 country
- A Phase 1 Clinical Trial of NTQ5082 in Healthy VolunteersNot yet recruitingNCT06560593Phase 11 country
- Vivifrail Program on the Degree of Debilitation in Hospitalized Patients After Venous Hemolysis in Acute Ischemic StrokeRecruitingNCT06391502Not applicable1 country
- Zanubrutinib in the Treatment of Relapsed/Refractory wAIHARecruitingNCT05922839Phase 21 country
- Prediction and Evaluation by ETCOc of Neonatal Hyperbilirubinemia CohortRecruitingNCT063415821 country
- CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of TherapyRecruitingNCT06212154Phase 11 country
- Biodex Training in Hemodialysis Females With OsteopeniaRecruitingNCT06223802Not applicable1 country
- Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic SyndromeRecruitingNCT05726916Phase 31 country
- Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBLRecruitingNCT05694312Phase 21 country
- The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic AnemiaRecruitingNCT06021977Phase 21 country
- Hemolysis During Pulsed-field and Radiofrequency AblationNot yet recruitingNCT060964281 country
- French National Cohort MATRIX "Renal and Systemic Thrombotic Microangiopathy"RecruitingNCT059912451 country
- A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNHRecruitingNCT05539248Phase 1/21 country
- A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic AnemiaEnrolling by invitationNCT04138927Phase 318 countries
- HEMolysis in a Percutaneous Axial Flow LVAD, Effects of Pentoxifylline in a Randomized Controlled TrialNot yet recruitingNCT04391231Phase 41 country
- Early vs. Late Tourniquet Release and Phlebotomy-Induced Hemolysis in the Emergency Department: TOURNI-EDCompletedNCT07617103Not applicable1 country
- A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNHActive, not recruitingNCT05389449Phase 315 countries
- Therapeutic Orientation Test in Thrombotic MicroangiopathyCompletedNCT04777435Not applicable1 country
- A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)Active, not recruitingNCT04624659Phase 317 countries
- A Study of Etavopivat in Patients With Thalassemia or Sickle Cell DiseaseCompletedNCT04987489Phase 26 countries
- Effects of Nitric Oxide on the Endothelium During Hemolysis.WithdrawnNCT03748082Phase 21 country
- Hereditary Spherocytosis and Vascular FunctionCompletedNCT04451785Not applicable1 country
- CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.Active, not recruitingNCT06231368Phase 11 country